Market-01.jpg
Pain Management Software Market to be Worth $3.7 billion by 2030 - Market Size, Share, Forecasts, & Trends Analysis Report with COVID-19 Impact by Markets N Research
January 18, 2023 09:00 ET | Markets N Research
Chicago, Jan. 18, 2023 (GLOBE NEWSWIRE) -- Markets N Research has recently released expansive research on Global Pain Management Software Market with 100+ market data Tables, Pie Chart, and Graphs...
Global Cancer Pain Market
Global Cancer Pain Market Report 2022-2027: Increase in Number of Pipeline Drugs and Growing Demand in Emerging Economies Presents Lucrative Expansion Opportunities
August 11, 2022 08:28 ET | Research and Markets
Dublin, Aug. 11, 2022 (GLOBE NEWSWIRE) -- The "Global Cancer Pain Market (2022-2027) by Type, Disease Indication, Application, and Geography, Competitive Analysis, Impact of Covid-19 with Ansoff...
22157.jpg
Global Oncology Partnering 2017-2022: Featuring Key Players AG Mednet, 3B Pharmaceuticals, Abbisko Therapeutics and Others
June 29, 2022 07:58 ET | Research and Markets
Dublin, June 29, 2022 (GLOBE NEWSWIRE) -- The "Global Oncology Partnering 2017-2022: Deal Trends, Players and Financials" report has been added to ResearchAndMarkets.com's offering. The Global...
Global Cancer Pain Market
Insights on the Cancer Pain Global Market to 2030 - Rising Healthcare Expenditure and Government Support Worldwide are Driving Growth
March 09, 2022 04:58 ET | Research and Markets
Dublin, March 09, 2022 (GLOBE NEWSWIRE) -- The "Global Cancer Pain Market, By Drug Type, By Disease Indication, Estimation & Forecast, 2017 - 2030" report has been added to...
logo long.jpg
Chronic Pain Market to Surpass US$ 108,814 Million by 2028, Says Coherent Market Insights (CMI)
November 17, 2021 08:40 ET | CMI
SEATTLE, Nov. 17, 2021 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global chronic pain market is estimated to be valued at US$ 64,068 million in 2020 and is expected to exhibit a...
AMR Logo.png
Global Pain Management Devices Market Size To Reach $5.76 Billion By 2028: Allied Market Research
July 26, 2021 08:27 ET | Allied Market Research
Portland, OR, July 26, 2021 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global Pain Management Devices Market garnered $3.68 billion in 2020, and is expected...
22157.jpg
Global Oncology Partnering Report 2021: Deal Trends, Players and Financials for 4700 Deals
July 21, 2021 04:48 ET | Research and Markets
Dublin, July 21, 2021 (GLOBE NEWSWIRE) -- The "Global Oncology Partnering 2015-2021: Deal Trends, Players and Financials" report has been added to ResearchAndMarkets.com's offering. The Global...
22157.jpg
Global Oncology Partnering Directory 2020 - Access to Over 4,000 Oncology Deal Records
February 05, 2021 08:28 ET | Research and Markets
Dublin, Feb. 05, 2021 (GLOBE NEWSWIRE) -- The "Global Oncology Partnering 2015-2020: Deal Trends, Players and Financials" report has been added to ResearchAndMarkets.com's offering. The Global...
22157.jpg
Global Cancer Pain Pipeline Review, H2 2020 Report - Therapeutics Assessment of 36 Companies & Respective Drug Profiles
December 23, 2020 08:43 ET | Research and Markets
Dublin, Dec. 23, 2020 (GLOBE NEWSWIRE) -- The "Cancer Pain - Pipeline Review, H2 2020" drug pipelines has been added to ResearchAndMarkets.com's offering. Cancer Pain - Pipeline Review, H2 2020,...
15-SORRENTO-Therapeutics-Logo-FINAL.png
Sorrento Therapeutics Releases Positive Results of Phase 1B Trial of Resiniferatoxin (RTX) Epidural in Cancer Patients with Reported Intractable Pain
September 22, 2020 14:30 ET | Sorrento Therapeutics, Inc.
Seventeen subjects with advanced cancer pain received epidural RTX (0.4 to 25 mcg).No dose limiting toxicities were reported.A majority of patients reported meaningful pain reduction of 30% or more...